Curesign Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 2

Curesign General Information

Description

Developer of medical devices designed to optimize oncology treatments. The company's technology and devices are based on integrating sensors with advanced signal processing and big data tools, enabling clinical teams to tailor patient-specific treatment for each cancer patient.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Tel Aviv
  • Israel
Primary Industry
Therapeutic Devices
Corporate Office
  • Tel Aviv
  • Israel

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Curesign Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Seed Round 01-Feb-2020 Completed Pre-Clinical Trials
To view Curesign’s complete valuation and funding history, request access »

Curesign Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Curesign Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Nacre Capital Venture Capital Minority
Peregrine Ventures Venture Capital Minority
To view Curesign’s complete investors history, request access »

Curesign FAQs

  • When was Curesign founded?

    Curesign was founded in 2019.

  • Where is Curesign headquartered?

    Curesign is headquartered in Tel Aviv, Israel.

  • What is the size of Curesign?

    Curesign has 4 total employees.

  • What industry is Curesign in?

    Curesign’s primary industry is Therapeutic Devices.

  • Is Curesign a private or public company?

    Curesign is a Private company.

  • What is Curesign’s current revenue?

    The current revenue for Curesign is .

  • Who are Curesign’s investors?

    Nacre Capital and Peregrine Ventures have invested in Curesign.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process